{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Blood group antigen",
      "COVID-19",
      "Glycosylation",
      "Infection",
      "SARS-CoV-2",
      "Spike protein"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34023935",
  "DateCompleted": {
    "Year": "2021",
    "Month": "08",
    "Day": "03"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "05",
        "Day": "22"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/s00109-021-02092-0"
    ],
    "Journal": {
      "ISSN": "1432-1440",
      "JournalIssue": {
        "Volume": "99",
        "Issue": "8",
        "PubDate": {
          "Year": "2021",
          "Month": "Aug"
        }
      },
      "Title": "Journal of molecular medicine (Berlin, Germany)",
      "ISOAbbreviation": "J Mol Med (Berl)"
    },
    "ArticleTitle": "Glycosylation is a key in SARS-CoV-2 infection.",
    "Pagination": {
      "StartPage": "1023",
      "EndPage": "1031",
      "MedlinePgn": "1023-1031"
    },
    "Abstract": {
      "AbstractText": [
        "SARS-CoV-2 causes the respiratory syndrome COVID-19 and is responsible for the current pandemic. The S protein of SARS-CoV-2-mediating virus binding to target cells and subsequent viral uptake is extensively glycosylated. Here we focus on how glycosylation of both SARS-CoV-2 and target cells crucially impacts SARS-CoV-2 infection at different levels: (1) virus binding and entry to host cells, with glycosaminoglycans of host cells acting as a necessary co-factor for SARS-CoV-2 infection by interacting with the receptor-binding domain of the SARS-CoV-2 spike glycoprotein, (2) innate and adaptive immune response where glycosylation plays both a protective role and contributes to immune evasion by masking of viral polypeptide epitopes and may add to the cytokine cascade via non-fucosylated IgG, and (3) therapy and vaccination where a monoclonal antibody-neutralizing SARS-CoV-2 was shown to interact also with a distinct glycan epitope on the SARS-CoV-2 spike protein. These evidences highlight the importance of ensuring that glycans are considered when tackling this disease, particularly in the development of vaccines, therapeutic strategies and serological testing."
      ],
      "CopyrightInformation": "\u00a9 2021. The Author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "i3S - Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, 4200-135, Porto, Portugal."
          },
          {
            "Identifier": [],
            "Affiliation": "IPATIMUP - Institute of Molecular Pathology and Immunology, University of Porto, 4200-135, Porto, Portugal."
          },
          {
            "Identifier": [],
            "Affiliation": "Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar, University of Porto, 4050-313, Porto, Portugal."
          }
        ],
        "LastName": "Reis",
        "ForeName": "Celso A",
        "Initials": "CA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany."
          }
        ],
        "LastName": "Tauber",
        "ForeName": "Rudolf",
        "Initials": "R"
      },
      {
        "Identifier": [
          "0000-0002-5980-6450"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany. veronique.blanchard@charite.de."
          }
        ],
        "LastName": "Blanchard",
        "ForeName": "V\u00e9ronique",
        "Initials": "V"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "J Mol Med (Berl)",
    "NlmUniqueID": "9504370",
    "ISSNLinking": "0946-2716"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Blood Group Antigens"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "spike protein, SARS-CoV-2"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adaptive Immunity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "immunology",
        "metabolism"
      ],
      "DescriptorName": "Blood Group Antigens"
    },
    {
      "QualifierName": [
        "immunology",
        "metabolism",
        "therapy"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Exocytosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Glycosylation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Host-Pathogen Interactions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunity, Innate"
    },
    {
      "QualifierName": [
        "immunology",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "immunology",
        "metabolism"
      ],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virus Internalization"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virus Replication"
    }
  ],
  "CoiStatement": "The authors declare no competing interests."
}